LVVVLivewire Ergogenics, Inc.
Price Chart
Loading chart...
About Livewire Ergogenics, Inc. (LVVV)
Livewire Ergogenics, Inc. (LVVV) is a Drug Manufacturers - Specialty & Generic company headquartered in Paso Robles, CA, United States whose shares trade over-the-counter on the Pink tier.
LiveWire Ergogenics acquires, manages, and licenses special purpose real estate properties conducive to discovering and developing high-quality, organically grown cannabinoid products for the health and wellness industry in California and the statewide distribution of these products through its operators and affiliate companies.
Products and services
The Company is focused on acquiring, managing, and licensing specialized “closed loop” turnkey cannabis real estate locations of fully compliant and permitted turnkey facilities to produce cannabis-based products and services in California and the state-wide distribution of these products.
LVVV key facts
- Ticker symbol
- LVVV
- Market tier
- Pink
- Sector
- Healthcare
- Headquarters
- Paso Robles, CA, United States
- Country of incorporation
- US
- Year of incorporation
- 2008
- Employees
- 3
- Estimated market cap
- $1.33M (as of Apr 9, 2025)
- Shares outstanding
- 1,903,979,092
- Reporting standard
- Alternative Reporting Standard
- Audit status
- Unaudited
- Fiscal year end
- 12/31
- Latest filing
- Quarterly Report (Jun 30, 2024)
Livewire Ergogenics, Inc. leadership
- Bill Hodson — CEO
- William P Riley III — President, Director, Comm.
- Jeff Dole — VP, Bus. Dev. & Corp. Rel.
- Tristan Cavato — IR Manager
Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with L
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for Livewire Ergogenics, Inc. (LVVV) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Drug Manufacturers - Specialty & Generic Companies on OTC Markets
Other OTC-traded companies in Drug Manufacturers - Specialty & Generic:
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Chief Executive Officer
Company Officers
Social Media
Business Details
Stock Details
Loading modules...